Zileuton: a new therapy for asthma or just the first of a new class of drugs.
Hendeles
L
L
University of Florida, Gainesville 32610, USA. hendeles@cop.health.ufl.edu
Marshik
P L
PL
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy*; D001250:Asthma, Exercise-Induced / Q000188:drug therapy; D001986:Bronchial Spasm / Q000139:chemically induced / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval; D006918:Hydroxyurea / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007975:Leukotriene B4 / Q000096:biosynthesis; D017998:Leukotriene D4 / Q000096:biosynthesis; D017999:Leukotriene E4 / Q000096:biosynthesis; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016859:Lipoxygenase Inhibitors; D007975:Leukotriene B4; D017998:Leukotriene D4; D017999:Leukotriene E4; D001241:Aspirin; C063449:zileuton; D006918:Hydroxyurea